Milestone Asset Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.18M Buy
16,957
+7,729
+84% +$905K 0.34% 80
2026
Q1
$1.11M Buy
9,228
+4,521
+96% +$522K 0.2% 108
2025
Q4
$496K Buy
4,707
+250
+6% +$23.5K 0.09% 154
2025
Q3
$374K Buy
4,457
+673
+18% +$55.4K 0.07% 177
2025
Q2
$300K Buy
+3,784
New +$301K 0.06% 177
2025
Q1
Sell
-3,033
Closed -$302K 236
2024
Q4
$302K Sell
3,033
-2,628
-46% -$271K 0.07% 198
2024
Q3
$643K Buy
+5,661
New +$673K 0.14% 123

Other funds holding MRK

Milestone Asset Management's MRK Position: Q2 2026 in Review

Milestone Asset Management increased its Merck (MRK) stake by 84% in Q2 2026, buying an estimated $905K and bringing the position to 16,957 shares worth $2.18M. The position accounts for 0.34% of the portfolio, ranked #80.

Milestone Asset Management first reported a position in MRK in Q3 2024 and has held it in 7 quarters since. 3,829 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Milestone Asset Management held 16,957 shares of Merck worth $2.18M as of Q2 2026.
  • Milestone Asset Management bought 7,729 Merck shares in Q2 2026, an estimated $905K.
  • Merck made up 0.34% of Milestone Asset Management's portfolio in Q2 2026, its #80 holding.
  • Milestone Asset Management first reported a position in Merck in Q3 2024 and has held it in 7 quarters since.
  • 3,829 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Milestone Asset Management's 13F filing for Q2 2026, filed 15 Jul 2026.